Related Experiment Videos
An age-structured model for pertussis transmission
1Department of Mathematics, University of Iowa, Iowa City 52242, USA.
Insights
The U.S. pertussis (whooping cough) vaccination program, using a mathematical model, shows minor future changes in disease incidence if maintained. This model accounts for waning immunity from infection and vaccination in children.
Area of Science:
- Epidemiology
- Mathematical Modeling
- Public Health
Background:
- Pertussis (whooping cough) vaccination in the U.S. involves multiple doses for young children.
- An age-structured demographic and epidemiologic model was developed to study pertussis transmission.
Observation:
- The model incorporates vaccination of infants and children.
- It accounts for the waning of immunity acquired through infection and vaccination.
Findings:
- Computer simulations from 1940-2040 predict minimal future changes in pertussis age distribution and incidence if the vaccination program remains at 1995 levels.
- The study investigated the sensitivity of these predictions to demographic, epidemiologic, and vaccination parameters.
Implications:
- Maintaining current vaccination levels is projected to stabilize pertussis dynamics.
- Understanding parameter sensitivities is crucial for assessing the robustness of vaccination program outcomes.
Abstract:
The vaccination program for pertussis (whooping cough) in the United States consists of giving multiple doses of pertussis vaccine to young children. A demographic model with a steady-state age distribution is used as a basis for building an epidemiologic model for the transmission of pertussis. This age-structured model includes vaccination of infants and children for pertussis with waning of both infection-acquired and vaccine-induced immunity. Computer simulations of the mathematical model between 1940 and 2040 show the changes that took place during the implementation phase of the U.S. program and predict only minor future changes in the age distribution and incidence of pertussis if the vaccination program is maintained at the 1995 level. The sensitivities of these results to changes in demographic and epidemiologic parameters, vaccine efficacy, duration of protection, and levels of vaccination coverage are investigated.